Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage Ovarian Tumors”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Large-scale testing (Phase 3)Study completedNCT00003644
What this trial is testing

Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 571
Not applicableStudy completedNCT00452985
What this trial is testing

Docetaxel and Carboplatin as First-line Chemotherapy in Early Stage as Well as Advanced or Metastatic Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Sanofi 30
Not applicableNot Yet RecruitingNCT07271914
What this trial is testing

PONDER: Pelvic Peritonectomy in Early Stage Ovarian Tumors

Who this might be right for
Early Stage Ovarian TumorsPeritoneal Carcinosis
Ospedale Santa Croce-Carle Cuneo 390
Testing effectiveness (Phase 2)Ended earlyNCT00090844
What this trial is testing

Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

Who this might be right for
Breast CancerHormone ChangesDrug Toxicity
University of South Florida 49
Early research (Phase 1)Looking for participantsNCT07310420
What this trial is testing

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Who this might be right for
Advanced Breast CancerEarly Breast Cancer
TerSera Therapeutics LLC 176
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Early research (Phase 1)Looking for participantsNCT06430541
What this trial is testing

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Who this might be right for
Breast CancerOvarian Cancer
University of Colorado, Denver 20
Large-scale testing (Phase 3)Looking for participantsNCT06963268
What this trial is testing

Validation of the Sentinel Lymph Node Technique in Early-stage Ovarian Cancer (SENTOV II)

Who this might be right for
Ovarian Neoplasms
Instituto de Investigacion Sanitaria La Fe 200
Not applicableStudy completedNCT00531570
What this trial is testing

Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma

Who this might be right for
Ovarian Neoplasms
NYU Langone Health 100
Testing effectiveness (Phase 2)WithdrawnNCT05201001
What this trial is testing

APX005M in Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Large-scale testing (Phase 3)Study completedNCT01530607
What this trial is testing

Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer

Who this might be right for
Breast Cancer
King Faisal Specialist Hospital & Research Center 416
Not applicableStudy completedNCT05372692
What this trial is testing

Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weijia Fang, MD 3
Not applicableStudy completedNCT00433602
What this trial is testing

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
European Organisation for Research and Treatment of Cancer - EORTC 64
Large-scale testing (Phase 3)WithdrawnNCT00328757
What this trial is testing

Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer

Who this might be right for
Gynecologic Neoplasms
Chiang Mai University 240
Not applicableStudy completedNCT00525460
What this trial is testing

Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function

Who this might be right for
Ovarian Cancer
Dana-Farber Cancer Institute 16
Large-scale testing (Phase 3)Study completedNCT00068601
What this trial is testing

S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer

Who this might be right for
Breast CancerInfertilityMenopausal Symptoms
SWOG Cancer Research Network 257
Testing effectiveness (Phase 2)Study completedNCT01164995
What this trial is testing

Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
The Netherlands Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00659373
What this trial is testing

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Who this might be right for
Breast CancerFatigueSleep Disorders
ETOP IBCSG Partners Foundation 86
Next Page